Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci

被引:4
|
作者
Ravaoarinoro, M
Therrien, C
机构
[1] HOSP HOTEL DIEU,DEPT MICROBIOL & INFECT DIS,MONTREAL,PQ,CANADA
[2] UNIV MONTREAL,DEPT MICROBIOL & IMMUNOL,MONTREAL,PQ H3C 3J7,CANADA
关键词
in vitro activity; antimicrobial agents; Gram positive cocci; RESISTANT STAPHYLOCOCCUS-AUREUS; TEICHOMYCETICUS-NOV-SP; TEICOPLANIN; ENTEROCOCCI; VANCOMYCIN;
D O I
10.1016/S0924-8579(96)00317-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to compare the in vitro activities of 9 antistaphylococcal agents including teicoplanin (TEI) against 275 non-repetitive clinical strains representing 15 species of staphylococci and 27 strains of Enterococcus (E.) faecalis, isolated from various specimens between 1991-1992 at a Canadian teaching hospital. The NCCLS agar dilution method was used (10(4) colony-forming units/spot). In terms of MIC(90), TEI and vancomycin (VAN) appeared to be the most potent antibiotics against all staphylococci tested (TEI: 2.0-4.0 mu g/ml; VAN: 1.0-2.0 mu g/ml; ciprofloxacin (CPF): 0.25-32 mu g/ml; cefazolin (CEF): 8.0-256 mu g/ml; methicillin (MET): 2.0->256 mu g/ml; imipenem (IMP): 1.0-32 mu g/ml; erythromycin (ERT): 16->256 mu g/ml; ampicillin (AMP): 16-128 mu g/ml; fusidic acid (FSA): 0.5-16 mu g/ml). Multiple resistant strains, including MET-resistant Staphylococcus (Staph.) aureus and Staph. epidermidis, were susceptible to TEI and VAN with respective MICs of 2-4 mu g/ml and 1-2 mu g/ml regardless of specimen type. Moreover, TEI was highly active against E. faecalis (MIC(90) for TEI and VAN: 0.5 and 4.0 mu g/ml, respectively).
引用
收藏
页码:167 / 170
页数:4
相关论文
共 50 条
  • [21] In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients
    Rolston, Kenneth V. I.
    Wang, Weiqun
    Nesher, Lior
    Shelburne, Samuel A.
    Prince, Randall A.
    JOURNAL OF ANTIBIOTICS, 2016, 69 (05) : 381 - 387
  • [22] Clinical efficacy of fosfomycin combinations against a variety of gram-positive cocci
    Coronado-Alvarez, Nieves M.
    Parra, Diego
    Parra-Ruiz, Jorge
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2019, 37 (01): : 4 - 10
  • [23] Novel pharmaceutical molecules against emerging resistant gram-positive cocci
    Manfredi, Roberto
    Sabbatani, Sergio
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (01) : 96 - 108
  • [24] In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection
    Silvestri, C.
    Cirioni, O.
    Arzeni, D.
    Ghiselli, R.
    Simonetti, O.
    Orlando, F.
    Ganzetti, G.
    Staffolani, S.
    Brescini, L.
    Provinciali, M.
    Offidani, A.
    Guerrieri, M.
    Giacometti, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (08) : 1759 - 1764
  • [25] Linezolid activity against clinical Gram-positive cocci with advanced antimicrobial drug resistance in Iran
    Houri, Hamidreza
    Kazemian, Hossein
    Ebrahim-Saraie, Hadi Sedigh
    Taji, Asieh
    Tayebi, Zahra
    Heidari, Hamid
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2017, 10 : 200 - 203
  • [26] In vitro activity of telavancin against recent Gram-positive clinical isolates:: results of the 2004-05 Prospective European Surveillance Initiative
    Draghi, Deborah C.
    Benton, Bret M.
    Krause, Kevin M.
    Thornsberry, Clyde
    Pillar, Chris
    Sahm, Daniel F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) : 116 - 121
  • [27] Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods
    Muller-Serieys, C
    Drugeon, HB
    Etienne, J
    Lascols, C
    Leclercq, R
    Nguyen, J
    Soussy, CJ
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (03) : 242 - 246
  • [28] Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review
    Françoise Van Bambeke
    Drugs, 2015, 75 : 2073 - 2095
  • [29] Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review
    Van Bambeke, Francoise
    DRUGS, 2015, 75 (18) : 2073 - 2095
  • [30] Comparative antimicrobial activities of linezolid and vancomycin against gram-positive clinical isolates from hospitals in Kuwait
    Phillips, OA
    Udo, EE
    Ali, AAM
    Mokaddas, EM
    MEDICAL PRINCIPLES AND PRACTICE, 2001, 10 (04) : 177 - 181